Heparanase 2 expression inversely correlates with bladder carcinoma grade and stage

Area of Science:

• Oncology
• Molecular Biology
• Biochemistry

Background:

• The pro-tumorigenic role of heparanase is established in cancer.
• The function of its homolog, heparanase 2 (Hpa2), in cancer remains largely unexplored.
• Understanding Hpa2's role is crucial for developing new bladder cancer therapies.

Purpose of the Study:

• To investigate the role of heparanase 2 (Hpa2) in bladder cancer.
• To determine the correlation between Hpa2 expression and tumor characteristics.
• To elucidate the mechanism by which Hpa2 influences bladder cancer progression.

Main Methods:

• Immunohistochemical analysis of Hpa2 expression in normal and cancerous bladder tissues.
• In vitro cell migration assays using bladder carcinoma cells (5637).
• Overexpression studies of Hpa2 in bladder carcinoma cells and subsequent tumor analysis.
• Masson's/Trichrome staining for collagen deposition and Lysyl Oxidase (LOX) staining.

Main Results:

• Hpa2 expression is decreased in bladder cancer compared to normal urothelium.
• High Hpa2 levels correlate significantly with low-grade and low-stage tumors.
• Exogenous Hpa2 inhibits bladder cancer cell migration, and its overexpression reduces tumor size and grade.
• Hpa2 overexpression leads to increased stromal cell infiltration and collagen deposition, associated with elevated LOX staining.

Conclusions:

• Hpa2 functions as a tumor suppressor in bladder cancer.
• Hpa2 preserves cellular differentiation and reduces cell motility.
• The tumor-suppressive activity of Hpa2 appears independent of heparanase activity and is linked to LOX expression.